Stage IVA Prostate Cancer AJCC v8 Active Not Recruiting Phase 3 Trials for Leuprolide (DB00007)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04455750A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyTreatment